Approach to loss of response to advanced therapies in inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

757

Figures (1-2)

Tables (1-1)

Sum=951

Publishing Process of This Article

Item

Count

Browse

Download

Sum=97

Jun 14, 2024 (publication date) through Jul 21, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastroenterol. Jun 14, 2024; 30(22): 2902-2919
Published online Jun 14, 2024. doi: 10.3748/wjg.v30.i22.2902

Figure 1 Management of loss of response to vedolizumab. PNR: Primary non-response; LOR: Loss of response.

Figure 2 Management of loss of response to ustekinumab. PNR: Primary non-response; LOR: Loss of response.

Citation: Vootukuru N, Vasudevan A. Approach to loss of response to advanced therapies in inflammatory bowel disease. World J Gastroenterol 2024; 30(22): 2902-2919
URL: https://www.wjgnet.com/1007-9327/full/v30/i22/2902.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i22.2902